BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20615132)

  • 1. (124)I positron emission tomography versus (131)I planar imaging in the identification of residual thyroid tissue and/or metastasis in patients who have well-differentiated thyroid cancer.
    Van Nostrand D; Moreau S; Bandaru VV; Atkins F; Chennupati S; Mete M; Burman K; Wartofsky L
    Thyroid; 2010 Aug; 20(8):879-83. PubMed ID: 20615132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.
    Van Nostrand D; Khorjekar GR; O'Neil J; Moreau S; Atkins FB; Kharazi P; Mete M; Chennupati SP; Burman KD; Wartofsky L
    J Nucl Med; 2012 Mar; 53(3):359-62. PubMed ID: 22315442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
    Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
    J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer.
    Van Nostrand D; Aiken M; Atkins F; Moreau S; Garcia C; Acio E; Burman K; Wartofsky L
    Thyroid; 2009 Aug; 19(8):849-55. PubMed ID: 19281428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
    Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detectability of foci of radioiodine uptake in the thyroid bed and neck comparing pinhole with parallel-hole collimators.
    Kulkarni K; Van Nostrand D; Mete M; Burman K; Wartofsky L
    Nucl Med Commun; 2011 May; 32(5):369-74. PubMed ID: 21394048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.
    Alzahrani AS; Abouzied ME; Salam SA; Mohamed G; Rifai A; Al Sugair A; Amin T
    Eur J Endocrinol; 2008 May; 158(5):683-9. PubMed ID: 18426827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.
    Shankar LK; Yamamoto AJ; Alavi A; Mandel SJ
    J Nucl Med; 2002 Jan; 43(1):72-6. PubMed ID: 11801706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
    Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
    AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer.
    Iwano S; Kato K; Nihashi T; Ito S; Tachi Y; Naganawa S
    Ann Nucl Med; 2009 Nov; 23(9):777-82. PubMed ID: 19787312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
    Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
    J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer.
    Wu D; Plyku D; Kulkarni K; Garcia C; Atkins F; Tefera E; Burman KD; Wartofsky L; Van Nostrand D
    Clin Nucl Med; 2021 Apr; 46(4):283-288. PubMed ID: 33492859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.
    Triggiani V; Giagulli VA; Iovino M; De Pergola G; Licchelli B; Varraso A; Dicembrino F; Valle G; Guastamacchia E
    Endocrine; 2016 Sep; 53(3):626-35. PubMed ID: 26499192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
    Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
    J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
    Shammas A; Degirmenci B; Mountz JM; McCook BM; Branstetter B; Bencherif B; Joyce JM; Carty SE; Kuffner HA; Avril N
    J Nucl Med; 2007 Feb; 48(2):221-6. PubMed ID: 17268018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
    Barwick T; Murray I; Megadmi H; Drake WM; Plowman PN; Akker SA; Chew SL; Grossman AB; Avril N
    Eur J Endocrinol; 2010 Jun; 162(6):1131-9. PubMed ID: 20212015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI versus ¹³¹I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma.
    Mihailovic J; Prvulovic M; Ivkovic M; Markoski B; Martinov D
    AJR Am J Roentgenol; 2010 Nov; 195(5):1197-203. PubMed ID: 20966328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.